Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Accountprinceon Jul 02, 2024 11:07pm
246 Views
Post# 36115671

Signs Signs Everywhere a Sign

Signs Signs Everywhere a SignCan't believe the stock price remains at bargain basement levels...but with very little cheap inventory available.  Signs...

1.  Now 116 of 150 plus 75% of 179 already done which is close to 90% of data...at expectations or is all 116 "exceeding expectations"?
2.  Board now has a Baxter connection, an ex-FDA expertise and of course Dr Walker...long standing directors moved out to make room for these guys.
3.  Walker and Seto exercised options recently with very substantial dollars laid out...both amount and timing very important clues.  Why now and why so much?
4.  Baxter 2020 Agreement - still shrouded in secrecy...nothing that has happened so far warranted any secrecy...what is still being kept secret?
5.  Sufficient cash on hand to see the company through trial completion...no financing pressures.
6.  Baxter is either doing spinoff into a separate public company or selling Vantive to private equity.

Even the negative nellies have gone silent or starting to change their tune.  We are finally and truly on the cusp of success.  As the song says...can't you read the sign?
<< Previous
Bullboard Posts
Next >>